is myasthenia gravis a fatal disease?
396985
While complications of myasthenia gravis are treatable, some can be life-threatening. Complications may include the following: Myasthenic crisis is a life-threatening condition that affects breathing and requires immediate treatment in order for the person to be able to breathe on their own.
1141346
Myasthenia gravis (MG) is a chronic autoimmune disorder in which antibodies destroy the communication between nerves and muscle, resulting in weakness of the skeletal muscles. Myasthenia gravis affects the voluntary muscles of the body, especially those that control the eyes, mouth, throat and limbs.
177407
Myasthenia gravis is an autoimmune disease, which means the immune system—which normally protects the body from foreign organisms—mistakenly attacks itself. Myasthenia gravis is caused by an error in the transmission of nerve impulses to muscles.
980512
Giant cell myocarditis: most fatal of autoimmune diseases.
1353151
Myasthenia gravis and multiple sclerosis (MS) may share immunological features, according to researchers who studied the rare case of a man who developed both illnesses.
448674
Amitabh Bachchan Shortly after the 'Coolie' incident, he was diagnosed with a muscle dysfunctional disorder - Myasthenia Gravis.
657407
Although MS is primarily mediated by T lymphocytes and MG primarily involves the destruction of the neuromuscular junction by antibodies, there are evidences that support both cell-mediated and humoral immunity are involved in the pathogenesis of both diseases.
1317765
Autoantibodies in the blood that target acetylcholine receptors are the key problem in myasthenia gravis. IVIG consists of immune globulins collected from donors and acts to destroy and neutralize these autoantibodies in the bloodstream and block the production of new autoantibodies.
1203030
The nurse recognizes which pathophysiologic change in the client diagnosed with myasthenia gravis? There is a defect in the transmission of nerve impulses to the skeletal muscles.
723120
Background Although overt involvement of the central nervous system (CNS) in myasthenia gravis (MG) is considered rare, hyperreflexia is a common and yet unexplained finding. Aquaporin 4 (AQP4), the target autoantigen in neuromyelitis optica, is expressed both in the CNS and in the neuromuscular junction.
1094337
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting particularly motor neurons for which no cure or effective treatment is available. Although the cause of ALS remains unknown, accumulative evidence suggests an autoimmune mechanism of pathogenesis.
1467027
A diagnosis of MS is not a death sentence. Multiple sclerosis is not fatal, except in very rare circumstances. During advanced stages of disease progression, it is possible to die from complications related to MS (such as infections or pneumonia). However, that is far from common.
1348821
Myasthenia gravis associated with peripheral neuropathy. We describe two patients with peripheral neuropathy who developed myasthenia gravis. One patient had an autoimmune sensory motor polyneuropathy with demyelinating and secondary axonal features associated with seronegative ocular myasthenia gravis.
1401656
Myotonic dystrophy is a progressive disease, meaning that symptoms worsen as a person gets older. Although evidence is limited, life expectancy appears to be reduced for people with myotonic dystrophy type 1 (DM1). The most common causes of death in people with DM1 are respiratory and cardiac (heart) symptoms.
461994
Deficiencies in acetylcholine can lead to myasthenia gravis, which is characterized by muscle weakness. Too little acetylcholine may also lead to Alzheimer's disease; symptoms include a decline in cognitive abilities and memory loss.
984979
In myasthenia gravis, the immune system produces antibodies that attack one type of receptor on the muscle side of the neuromuscular junction—the receptors that respond to the neurotransmitter acetylcholine. As a result, communication between the nerve cell and the muscle is disrupted.
1443775
Acetylcholine esterase (AChE) inhibitors are considered to be the basic treatment of myasthenia gravis (MG). Edrophonium is primarily used as a diagnostic tool owing to its short half-life. Pyridostigmine is used for long-term maintenance. High doses of corticosteroids commonly are used to suppress autoimmunity.